A nonrandom association of breast implants and the formation of desmoid tumors [0.03%]
隆胸植入物与包涵性纤维瘤病发病相关性的病例对照研究
Philippos Apolinario Costa,Staci Marbin,Bruna Menon Loureiro Apolinario Costa et al.
Philippos Apolinario Costa et al.
Background: Studies suggest that surgical breast augmentation with implants is a risk factor for breast desmoid tumors. The statistical strength of this correlation is unknown, as evidence is limited to anecdotal reports....
Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID-19: Prospective single institutional study [0.03%]
评估乳腺癌合并新冠肺炎患者放射治疗早期不良反应：前瞻性单中心研究
Sofiane Allali,Vincent Servois,Arnaud Beddok et al.
Sofiane Allali et al.
The COVID-19 caused by the SARS-CoV-2 coronavirus is at the origin of a global pandemic. This pandemic has prompted the current health system to reorganize and rethink the care offered by health establishments. We report the early toxicity ...
Why proper characterization of breast cancer subtypes makes a difference in patient care [0.03%]
为何正确的乳腺癌亚型分类会对患者治疗产生影响
Shahla Masood
Shahla Masood
Trends, survival outcomes, and predictors of nonadherence to mastectomy guidelines for nonmetastatic inflammatory breast cancer [0.03%]
非转移性炎性乳腺癌乳房切除术指南的依从性趋势、生存结果及预测因素
Anna Lehrberg,Mohamad Sebai,Daniel Finn et al.
Anna Lehrberg et al.
Background: The Current National Comprehensive Cancer Network guidelines recommend modified radical mastectomy (MRM) as the surgical treatment of choice for nonmetastatic inflammatory breast cancer (IBC). Limited studies ...
Occurrence of residual disease in specimens of re-excision surgery in patients with positive margins of primary quadrantectomy [0.03%]
乳腺象限切除术阳性切缘患者再次切除标本中残余病灶的检出率
Majid Akrami,Hamidreza Hosseinpour,Masoumeh Ghoddusi Johari et al.
Majid Akrami et al.
Performing a re-intervention following a positive margin after primary lumpectomy in patients with breast cancer entails several disadvantages such as additional costs and postponing the follow-up treatments. In the present study, we sought...
Eribulin combined with radiation therapy in a young patient re-irradiated for a new lesion of breast cancer [0.03%]
依西美坦联合放射治疗用于乳腺癌新发病灶的再放疗年轻患者治療
Oulimata Dieng,Valerie Laurence,Christelle Logerot et al.
Oulimata Dieng et al.
Eribulin is widely used in the treatment of metastatic breast cancer, with a manageable toxicity profile. This aggressive disease often requires systemic and local treatments, comprising surgery or radiotherapy. However, eribulin is usually...
Case Reports
The breast journal. 2021 Oct;27(10):787-790. DOI:10.1111/tbj.14278 2021
Maria Makuszewska,Łukasz Fus,Robert Bartoszewicz et al.
Maria Makuszewska et al.
Facial nerve (FN) palsy, as a solitary symptom, resulting from metastatic tumor is not frequent. In this article, we report an unusual case of the breast cancer metastasis to the labyrinthine segment of a facial nerve. ...
Case Reports
The breast journal. 2021 Nov;27(11):838-840. DOI:10.1111/tbj.14279 2021
Time to development and imaging features of new calcifications in the treated breast after breast-conserving therapy [0.03%]
保乳术后治疗侧乳腺新钙化的发生时间及影像学征象研究
Lauren Q Chang Sen,Annie Ko,Miral M Patel et al.
Lauren Q Chang Sen et al.
Objective: The purpose of our study was to analyze the time to development, malignancy rate, location, and mammographic features of new calcifications in the treated breast after breast-conserving therapy (BCT). ...
Rebound of background parenchymal enhancement post cessation of tamoxifen therapy [0.03%]
他莫昔芬治疗停药后的背景实质增强反弹现象
Nicole Marie Sakla,Tej Phatak,Luke Partyka
Nicole Marie Sakla